Annual Operating Profit
-$167.31 M
+$5.13 M+2.97%
December 31, 2023
Summary
- As of February 7, 2025, PHAT annual operating income is -$167.31 million, with the most recent change of +$5.13 million (+2.97%) on December 31, 2023.
- During the last 3 years, PHAT annual operating profit has fallen by -$41.65 million (-33.14%).
- PHAT annual operating profit is now -13558.12% below its all-time high of -$1.23 million, reached on December 31, 2018.
Performance
PHAT Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$70.80 M
+$6.50 M+8.41%
September 30, 2024
Summary
- As of February 7, 2025, PHAT quarterly operating income is -$70.80 million, with the most recent change of +$6.50 million (+8.41%) on September 30, 2024.
- Over the past year, PHAT quarterly operating profit has increased by +$6.50 million (+8.41%).
- PHAT quarterly operating profit is now -26316.42% below its all-time high of -$268.00 thousand, reached on September 30, 2018.
Performance
PHAT Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$287.93 M
-$35.14 M-13.90%
September 30, 2024
Summary
- As of February 7, 2025, PHAT TTM operating income is -$287.93 million, with the most recent change of -$35.14 million (-13.90%) on September 30, 2024.
- Over the past year, PHAT TTM operating profit has dropped by -$35.14 million (-13.90%).
- PHAT TTM operating profit is now -107334.70% below its all-time high of -$268.00 thousand, reached on September 30, 2018.
Performance
PHAT TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
PHAT Operating Profit Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +3.0% | +8.4% | -13.9% |
3 y3 years | -33.1% | -51.8% | -67.0% |
5 y5 years | -10000.0% | -51.8% | -67.0% |
PHAT Operating Profit Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -23.9% | +3.0% | -135.4% | +8.4% | -113.2% | at low |
5 y | 5-year | -57.5% | +3.0% | -351.1% | +8.4% | -361.6% | at low |
alltime | all time | <-9999.0% | +3.0% | <-9999.0% | +14.7% | <-9999.0% | at low |
Phathom Pharmaceuticals Operating Profit History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$70.80 M(-8.4%) | -$287.93 M(+13.9%) |
Jun 2024 | - | -$77.30 M(+10.5%) | -$252.79 M(+22.0%) |
Mar 2024 | - | -$69.95 M(+0.1%) | -$207.19 M(+23.8%) |
Dec 2023 | -$167.31 M(-3.0%) | -$69.88 M(+96.0%) | -$167.31 M(+16.1%) |
Sep 2023 | - | -$35.66 M(+12.5%) | -$144.08 M(-4.6%) |
Jun 2023 | - | -$31.70 M(+5.4%) | -$150.95 M(-8.3%) |
Mar 2023 | - | -$30.08 M(-35.5%) | -$164.61 M(-4.5%) |
Dec 2022 | -$172.44 M(+27.7%) | -$46.64 M(+9.7%) | -$172.44 M(+8.6%) |
Sep 2022 | - | -$42.53 M(-6.2%) | -$158.84 M(+6.3%) |
Jun 2022 | - | -$45.36 M(+19.7%) | -$149.45 M(+7.2%) |
Mar 2022 | - | -$37.91 M(+14.7%) | -$139.40 M(+3.2%) |
Dec 2021 | -$135.08 M | -$33.04 M(-0.3%) | -$135.08 M(-12.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2021 | - | -$33.14 M(-6.2%) | -$154.48 M(+0.2%) |
Jun 2021 | - | -$35.32 M(+5.2%) | -$154.17 M(+11.0%) |
Mar 2021 | - | -$33.58 M(-36.0%) | -$138.87 M(+10.5%) |
Dec 2020 | -$125.67 M(+18.3%) | -$52.44 M(+59.7%) | -$125.67 M(+41.3%) |
Sep 2020 | - | -$32.83 M(+64.0%) | -$88.92 M(+42.6%) |
Jun 2020 | - | -$20.02 M(-1.7%) | -$62.37 M(-50.2%) |
Mar 2020 | - | -$20.38 M(+29.8%) | -$125.36 M(+18.0%) |
Dec 2019 | -$106.22 M(+8570.6%) | -$15.69 M(+149.8%) | -$106.22 M(+16.8%) |
Sep 2019 | - | -$6.28 M(-92.4%) | -$90.97 M(+7.1%) |
Jun 2019 | - | -$83.01 M(+6671.1%) | -$84.96 M(+4268.1%) |
Mar 2019 | - | -$1.23 M(+171.8%) | -$1.95 M(+170.5%) |
Dec 2018 | -$1.23 M | -$451.00 K(+68.3%) | -$719.00 K(+168.3%) |
Sep 2018 | - | -$268.00 K | -$268.00 K |
FAQ
- What is Phathom Pharmaceuticals annual operating income?
- What is the all time high annual operating profit for Phathom Pharmaceuticals?
- What is Phathom Pharmaceuticals annual operating profit year-on-year change?
- What is Phathom Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Phathom Pharmaceuticals?
- What is Phathom Pharmaceuticals quarterly operating profit year-on-year change?
- What is Phathom Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Phathom Pharmaceuticals?
- What is Phathom Pharmaceuticals TTM operating profit year-on-year change?
What is Phathom Pharmaceuticals annual operating income?
The current annual operating profit of PHAT is -$167.31 M
What is the all time high annual operating profit for Phathom Pharmaceuticals?
Phathom Pharmaceuticals all-time high annual operating income is -$1.23 M
What is Phathom Pharmaceuticals annual operating profit year-on-year change?
Over the past year, PHAT annual operating income has changed by +$5.13 M (+2.97%)
What is Phathom Pharmaceuticals quarterly operating income?
The current quarterly operating profit of PHAT is -$70.80 M
What is the all time high quarterly operating profit for Phathom Pharmaceuticals?
Phathom Pharmaceuticals all-time high quarterly operating income is -$268.00 K
What is Phathom Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, PHAT quarterly operating income has changed by +$6.50 M (+8.41%)
What is Phathom Pharmaceuticals TTM operating income?
The current TTM operating profit of PHAT is -$287.93 M
What is the all time high TTM operating profit for Phathom Pharmaceuticals?
Phathom Pharmaceuticals all-time high TTM operating income is -$268.00 K
What is Phathom Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, PHAT TTM operating income has changed by -$35.14 M (-13.90%)